Blood Cancer: Medical Treatments

Department of Health and Social Care written question – answered on 3rd August 2020.

Alert me about debates like this

Photo of Alex Norris Alex Norris Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, how many patients with (a) blood cancer and (b) multiple myeloma have had their treatment switched from intravenous to oral treatment during the covid-19 outbreak; and what assessment he has made of the potential long term effect on patients of switching treatment regimens.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Holding answer received on 25 June 2020

As at 23 June 2020, 230 patients with myeloma, 32 patients with mantle cell lymphoma, and 28 patients with acute myeloid leukaemia have had applications for treatment with oral therapies approved. These applications were all supported by clinicians.

The outcomes related to these new options can only be assessed in the long term and some audits of these patients are already underway.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.